These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38303916)

  • 1. Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis.
    Lacy SC; Kinno M; Joyce C; Yu MD
    Int J Heart Fail; 2024 Jan; 6(1):36-43. PubMed ID: 38303916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulants in patients with atrial fibrillation and bioprosthetic valve replacement: A meta-analysis.
    Lacy SC; Saint Croix GR; Porter K; Latib A; Beohar N
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):E1007-E1016. PubMed ID: 34383369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
    Suppah M; Kamal A; Saadoun R; Baradeiya AMA; Abraham B; Alsidawi S; Sorajja D; Fortuin FD; Arsanjani R
    Am J Cardiol; 2023 Nov; 206():132-150. PubMed ID: 37703679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
    de Lucena LA; Freitas MAA; Souza AKC; Silva CHA; Watanabe JMF; Guedes FL; Almeida JB; de Oliveira RA
    J Thromb Thrombolysis; 2024 Mar; 57(3):381-389. PubMed ID: 38281231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
    Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
    Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve.
    Cao Y; Zheng Y; Li S; Liu F; Xue Z; Yin K; Luo J
    Front Cardiovasc Med; 2022; 9():899906. PubMed ID: 35783817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Oliva A; Ioppolo AM; Chiarito M; Cremonesi A; Azzano A; Miccichè E; Mangiameli A; Ariano F; Ferrante G; Reimers B; Garot P; Amabile N; Mehran R; Condorelli G; Stefanini G; Cao D
    J Am Heart Assoc; 2024 Aug; 13(16):e034815. PubMed ID: 39119987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Yan J; Liu M; Zhang Y; Yang D; An F
    Clin Cardiol; 2022 Oct; 45(10):1002-1010. PubMed ID: 36030549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Direct Oral Anticoagulants and Vitamin K Antagonists in Preventing Stroke in Patients With Atrial Fibrillation and Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Sinha T; Kaur M; Mayow AH; Soe TM; Khreis K; Chaudhari SS; Kholoki S; Hirani S
    Cureus; 2024 Jun; 16(6):e62606. PubMed ID: 39027793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
    Li D; Chang P; Zhang H; Bai F; Wu Q
    Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
    Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Troisi F; Guida P; Vitulano N; Quadrini F; Di Monaco A; Patti G; Grimaldi M
    Am J Cardiol; 2024 May; 218():77-85. PubMed ID: 38458580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis.
    Gao X; Huang D; Hu Y; Chen Y; Zhang H; Liu F; Luo J
    Front Cardiovasc Med; 2022; 9():833329. PubMed ID: 35615562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists.
    Tscharre M; Steiner D; Mutschlechner D; Ay C; Gremmel T
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102332. PubMed ID: 38404942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A
    Li X; Li R; Zhu W; Wu D
    Int J Cardiol Heart Vasc; 2024 Dec; 55():101512. PubMed ID: 39324035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.